Biological Indicators Market Analysis | 2022-2026

“The Biological Indicators Market was estimated at US$ 345.2 million in 2020 and is expected to grow at a CAGR of 5.7% during 2022-2026 to reach US$ 480.7 million by 2026.”

Wish to get a free sample? Register Here

Market Dynamics

Introduction

Biological Indicators as defined by ISO and ANSI/AAMI are test systems containing viable microorganisms offering a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, offering a level of confidence in the process.

Market Drivers

Biological indicators exhibit reliable results when compared to chemical indicators, thus driving product preference.

• It is considered a gold standard for the assessment of sterilization. The rise in R&D activities coupled with strict government regulations are the key factors expected to propel the product demand.

• In addition, growing demand for medical devices and medicines owing to the high prevalence of chronic diseases such as diabetes, asthma, cancer, and arthritis are likely to augment the market growth.

COVID-19 Impact

The ongoing COVID-19 pandemic has positively influenced the biological indicators industry due to the increasing surge of coronavirus cases across the globe. The rising epidemiological numbers around the world create a surging need for biological indicators, thus boosting product demand.

Segments Analysis

End Use Trends

“The hospital segment dominates the market during the forecast period.”

The biological indicators market has been segmented into hospitals, pharmaceutical companies, and others. Under these, the hospital segment held a substantial market share and is likely to register the fastest CAGR in the following years. This is mainly attributed to the growing number of sterilization procedures that are repeatedly carried out in hospitals. Moreover, stringent regulatory guidelines for the sterilization of biologics, medical devices, and drugs are propelling the biological indicators market.

Regional Analysis

“The market in North America garnered a significant market share and is projected to grow at a steady CAGR during the forecast period.”

This is mainly attributed to advanced healthcare infrastructure, increasing awareness among the population, growing favorable government initiatives, and increasing prevalence of diseases due to lifestyle change, which further augments regional growth.

Want to know which region offers the best growth opportunities? Register Here

Key Players

The market is highly populated with the presence of several local, regional, and global players. Most of the major players compete in some of the governing factors including price, product offerings, regional presence, etc.  

The following are the key players in the global biological indicators market (arranged alphabetically).

• 3M (The U.S),
• Advanced Sterilization (The U.S), and
• Bag Health Care (Germany).
• Cantel Medical (The U.S),
• Fuze Medical (The U.S),
• Getinge Group (Sweden),
• Hu-Friedy (The U.S),
• Matachana (Spain),
• Mesa Laboratories (The U.S),
• Steris (The U.S),

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. 

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. 

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Option

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players).
• SWOT analysis of key players (up to 3 players).

Market Segmentation

• Current market segmentation of any one of the product types by application type.  

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.